Lifang Guo

473 total citations
25 papers, 375 citations indexed

About

Lifang Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lifang Guo has authored 25 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Lifang Guo's work include Angiogenesis and VEGF in Cancer (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Research and Treatments (3 papers). Lifang Guo is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Research and Treatments (3 papers). Lifang Guo collaborates with scholars based in China and United States. Lifang Guo's co-authors include Yan Fu, Nan Song, Lin Jia, Ting He, Feifei Qi, Yongzhang Luo, Shan Wang, Zirui Wan, Yang Chen and Guanghua Liu and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Lifang Guo

24 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifang Guo China 11 231 136 82 43 34 25 375
Zumin Xu China 13 294 1.3× 141 1.0× 109 1.3× 47 1.1× 44 1.3× 24 427
Aihua Sui China 14 310 1.3× 171 1.3× 87 1.1× 41 1.0× 56 1.6× 38 491
Karim Mrouj France 3 173 0.7× 70 0.5× 102 1.2× 59 1.4× 33 1.0× 5 366
Gianmarco Villano Italy 13 187 0.8× 115 0.8× 49 0.6× 39 0.9× 29 0.9× 28 426
Sarani Ghoshal United States 10 201 0.9× 117 0.9× 115 1.4× 47 1.1× 29 0.9× 15 529
Jakub Kryczka Poland 13 192 0.8× 104 0.8× 97 1.2× 35 0.8× 43 1.3× 23 381
Hulin Chang China 14 277 1.2× 177 1.3× 83 1.0× 55 1.3× 49 1.4× 26 525
Siyang Dong China 12 295 1.3× 195 1.4× 87 1.1× 32 0.7× 27 0.8× 18 494
Lalita Yadav India 5 213 0.9× 153 1.1× 134 1.6× 35 0.8× 30 0.9× 13 407

Countries citing papers authored by Lifang Guo

Since Specialization
Citations

This map shows the geographic impact of Lifang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Guo more than expected).

Fields of papers citing papers by Lifang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Guo. The network helps show where Lifang Guo may publish in the future.

Co-authorship network of co-authors of Lifang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Lifang Guo. A scholar is included among the top collaborators of Lifang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifang Guo. Lifang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Lifang, Qing Xue, Bixiao Cui, et al.. (2025). Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia. Epilepsia. 66(7). 2339–2352. 1 indexed citations
3.
Wang, Yujiao, Yihe Wang, Lifang Guo, et al.. (2024). Spatial transcriptomics in focal cortical dysplasia type IIb. Acta Neuropathologica Communications. 12(1). 185–185. 3 indexed citations
4.
Miao, Yang, et al.. (2023). Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity. Nature Communications. 14(1). 5740–5740. 24 indexed citations
5.
Guo, Lifang, et al.. (2023). Pre-clinical Efficacy and Safety Pharmacology of PEGylatedRecombinant Human Endostatin. Current Molecular Medicine. 24(3). 389–396. 2 indexed citations
6.
Guo, Lifang, et al.. (2021). Prognostic Significance of CTNNB1 Mutation in Recurrence of Sporadic Desmoid Tumors. Future Oncology. 17(4). 435–442. 7 indexed citations
7.
8.
Ren, Lulu, Lingling Xuan, Feifei Han, et al.. (2020). Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape. Toxicology and Applied Pharmacology. 401. 115076–115076. 17 indexed citations
9.
Wan, Zirui, Lifang Guo, Pengfei Li, et al.. (2020). Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters. Journal of Clinical Pharmacy and Therapeutics. 45(5). 1159–1167. 8 indexed citations
10.
Ren, Lulu, Feifei Han, Lingling Xuan, et al.. (2019). Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation. Free Radical Biology and Medicine. 145. 357–373. 40 indexed citations
11.
Guo, Lifang, et al.. (2019). Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys. Life Sciences. 238. 116967–116967. 1 indexed citations
12.
Guo, Lifang, et al.. (2019). Biophysical and biological characterization of PEGylated recombinant human endostatin. Clinical and Experimental Pharmacology and Physiology. 46(10). 920–927. 9 indexed citations
13.
Geng, Xingchao, Lifang Guo, Li Liu, et al.. (2018). A pre-clinical safety study of PEGylated recombinant human endostatin (M 2 ES) in Sprague Dawley rats. Regulatory Toxicology and Pharmacology. 95. 190–197. 4 indexed citations
14.
Qi, Feifei, Ting He, Lin Jia, et al.. (2015). The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2. Clinical Cancer Research. 21(13). 3071–3080. 31 indexed citations
15.
Guo, Lifang, Yang Chen, Ting He, et al.. (2015). Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis. Molecular Medicine Reports. 11(5). 3473–3480. 4 indexed citations
16.
Jia, Lin, Lifang Guo, Wen Nie, et al.. (2015). Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats. Acta Pharmacologica Sinica. 36(7). 847–854. 12 indexed citations
17.
Guo, Lifang, Xingchao Geng, Yang Chen, et al.. (2014). Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys. Regulatory Toxicology and Pharmacology. 69(3). 512–523. 10 indexed citations
18.
Guo, Lifang, Runtao Gao, Junji Xu, et al.. (2014). AdLTR2EF1α-FGF2-mediated prevention of fractionated irradiation-induced salivary hypofunction in swine. Gene Therapy. 21(10). 866–873. 21 indexed citations
19.
He, Ting, Feifei Qi, Lin Jia, et al.. (2014). MicroRNA‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2. The Journal of Pathology. 232(5). 499–508. 84 indexed citations
20.
Chen, Yang, Guanghua Liu, Lifang Guo, et al.. (2014). Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. International Journal of Cancer. 136(1). 182–194. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zumin Xu Breakdown of academic impact, for papers by Aihua Sui Breakdown of academic impact, for papers by Karim Mrouj Breakdown of academic impact, for papers by Gianmarco Villano Breakdown of academic impact, for papers by Sarani Ghoshal Breakdown of academic impact, for papers by Jakub Kryczka Breakdown of academic impact, for papers by Hulin Chang Breakdown of academic impact, for papers by Siyang Dong Breakdown of academic impact, for papers by Lalita Yadav
Rankless by CCL
2026